Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


An Exploratory, Blinded, Randomized, Placebo-controlled Study in Subjects With Depressive Disorder to Investigate the Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced (Partial) Symptoms Response


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01809340

Organisation Name: Janssen Research & Development, LLC

Overal Status: Terminated

Start Date: June 2013

Last Update: June 30, 2015

Lead Sponsor: Janssen Research & Development, LLC

Brief Summary: The purpose of this study is to assess whether the antidepressant effect from intravenous (IV) ketamine treatment can be maintained by minocycline compared to placebo after IV ketamine treatment is stopped.

Conditions:
  • Depressive Disorder


Total execution time in seconds: 1.5904350280762